Cathie Wood Bets Big on SpaceX Even as Elon Musk Warns Short Sellers — Ark Keeps Dumping Robinhood Sharesbenzinga_article·14 hours agoPRME-2.59%HOOD-1.96%
Prime Medicine (NASDAQ:PRME) Shares Down 6.5% - Should You Sell?Market Beat·Jul 13 at 12:00 PMPRME-2.59%
LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)Tip Ranks·Jul 11 at 09:35 AMPRME-2.59%RANK+0.12%
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal BattleUnusual Whales·Jul 8 at 01:27 PMBEAM-2.08%PRME-2.59%
Prime Medicine posts corporate deck highlighting prime-editing platform, lead programs in Wilson disease and AATDPUBT·Jul 8 at 07:22 AMPRME-2.59%
Prime Medicine wins arbitration with Beam over AATD therapy PM647PUBT·Jul 8 at 07:04 AMPRME-2.59%BEAM-2.08%
This Caseys Analyst Turns Bullish; Here Are Top 3 Upgrades For Mondaybenzinga_article·Jun 29 at 07:42 AMCASY+1.09%PRME-2.59%
Prime Medicine says New Zealand clears clinical trial application for Wilson disease therapy PM577aPUBT·Jun 18 at 07:03 AMPRME-2.59%
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?Simplywall·Jun 18 at 05:59 AMPRME-2.59%
JonesTrading Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)Tip Ranks·May 8 at 02:16 PMPRME-2.59%XBI+0.23%
Wedbush Keeps Their Buy Rating on Prime Medicine, Inc. (PRME)Tip Ranks·May 8 at 12:15 PMPRME-2.59%IBB+0.90%
Prime Medicine shares are trading lower after the company reported worse-than-expected Q1 sales results.benzinga_article·May 7 at 11:58 AMPRME-2.59%IBBQ+0.60%
